Literature DB >> 8955242

Serum amylase and lipase in the evaluation of acute abdominal pain.

C W Chase1, D E Barker, W L Russell, R P Burns.   

Abstract

The purpose of this study was to determine 1) the incidence and magnitude of elevation in admission serum amylase and lipase levels in extrapancreatic etiologies of acute abdominal pain, and 2) the test most closely associated with the diagnosis of acute pancreatitis. Serum amylase and lipase levels were obtained in 306 patients admitted for evaluation of acute abdominal pain. Patients were categorized by anatomic location of identified pathology. Logistic regression analysis was used to compare the enzyme levels between patient groups and to determine the correlation between elevation in serum amylase and lipase. Twenty-seven (13%) of 208 patients with an extrapancreatic etiology of acute abdominal pain demonstrated an elevated admission serum amylase level with a maximum value of 385 units (U)/L (normal range 30-110 U/L). Twenty-six (12.5%) of these 208 patients had an elevated admission serum lipase value with a maximum of 3685 U/L (normal range 5-208 U/L). Of 48 patients with abdominal pain resulting from acute pancreatitis, admission serum amylase ranged from 30 to 7680 U/L and lipase ranged from 5 to 90,654 U/L. Both serum amylase and lipase elevations were positively associated with a correct diagnosis of acute pancreatitis (P < 0.001) with diagnostic efficiencies of 91 and 94 per cent, respectively. A close correlation between elevation of admission serum amylase and lipase was observed (r = 0.87) in both extrapancreatic and pancreatic disease processes. Serum amylase and lipase levels may be elevated in nonpancreatic disease processes of the abdomen. Significant elevations (greater than three times upper limit of normal) in either enzyme are uncommon in these disorders. The strong correlation between elevations in the two serum enzymes in both pancreatic and extrapancreatic etiologies of abdominal pain makes them redundant measures. Serum lipase is a better test than serum amylase either to exclude or to support a diagnosis of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955242

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  17 in total

1.  Using the literature to evaluate diagnostic tests: amylase or lipase for diagnosing acute pancreatitis?

Authors:  Julie M Beauregard; Jennifer A Lyon; Corey Slovis
Journal:  J Med Libr Assoc       Date:  2007-04

Review 2.  Resveratrol: a medical drug for acute pancreatitis.

Authors:  Zhen-Hua Ma; Qing-Yong Ma
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

3.  Analyses of hospital administrative data that use diagnosis codes overestimate the cases of acute pancreatitis.

Authors:  Shreyas Saligram; David Lo; Melissa Saul; Dhiraj Yadav
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

Review 4.  Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.

Authors:  Gianluca Rompianesi; Angus Hann; Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

5.  The role of routine assays of serum amylase and lipase for the diagnosis of acute abdominal pain.

Authors:  Paul A Sutton; David J Humes; Gemma Purcell; Janette K Smith; Frances Whiting; Tom Wright; Linda Morgan; Dileep N Lobo
Journal:  Ann R Coll Surg Engl       Date:  2009-04-30       Impact factor: 1.891

6.  Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases.

Authors:  C A Müller; S Appelros; W Uhl; M W Büchler; A Borgström
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 7.  Significant elevations of serum lipase not caused by pancreatitis: a systematic review.

Authors:  Ahmer M Hameed; Vincent W T Lam; Henry C Pleass
Journal:  HPB (Oxford)       Date:  2014-06-03       Impact factor: 3.647

8.  Eliminating amylase testing from the evaluation of pancreatitis in the emergency department.

Authors:  Kathryn A Volz; Daniel C McGillicuddy; Gary L Horowitz; Richard E Wolfe; Nina Joyce; Leon D Sanchez
Journal:  West J Emerg Med       Date:  2010-09

9.  Diagnostic dilemma of hyperamylasaemia in acute abdominal emergencies.

Authors:  A G Acheson; M Yousaf; C L Griffiths; O M Taylor
Journal:  Ulster Med J       Date:  2000-05

Review 10.  Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis.

Authors:  Susanta Meher; Tushar Subhadarshan Mishra; Prakash Kumar Sasmal; Satyajit Rath; Rakesh Sharma; Bikram Rout; Manoj Kumar Sahu
Journal:  J Biomark       Date:  2015-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.